Original Research
Published on 17 Apr 2025
α-Mangostin prevents diabetic cardiomyopathy by inhibiting oxidative damage and lipotoxicity through the AKT–FOXO1–CD36 pathway
in Cardiovascular and Smooth Muscle Pharmacology
- 204 views
Original Research
Published on 17 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology
Review
Published on 17 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Accepted on 16 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology
Review
Accepted on 15 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology
Mini Review
Published on 15 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Accepted on 14 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 14 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology
Editorial
Accepted on 11 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology
Review
Accepted on 11 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology
Review
Published on 10 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology
Mini Review
Accepted on 08 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology
Mini Review
Accepted on 08 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology
Review
Accepted on 07 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology
Review
Accepted on 07 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Accepted on 07 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology
Review
Published on 04 Apr 2025
in Cardiovascular and Smooth Muscle Pharmacology